Should metformin still be the first-line of treatment in type 2 diabetes mellitus? A comprehensive review and suggested algorithm

For more than a century, the high occurrences of coronary and peripheral artery diseases in diabetes mellitus patients has been well recognised; despite that, the ability to improve CV event rates by optimizing glycaemic control has remained elusive. Nevertheless, the last decade has seen several ca...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes & metabolic syndrome clinical research & reviews 2019-05, Vol.13 (3), p.1935-1942
Hauptverfasser:	Bin Hussain, Azza Khalifa, Abdelgadir, Elamin, Rashid, Fauzia, Al Haj, Abeer, Thadani, Puja, Bashier, Alaaeldin M.K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Algorithms Blood Glucose - analysis Diabetes Mellitus, Type 2 - drug therapy Humans Hypoglycemic Agents - therapeutic use Metformin - therapeutic use Prognosis Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!